Herceptin Regimen Minus Adriamycin Increases Survival With Less Toxicity
Alimta Reduces Risk Of Progression In Patients Aged 70 Years or Older
Family History of BRCA Mutation Does Not Equal Increased Risk
Daily Vitamin E Supplements Can Lead to Increased PCa Risk
Digital Immunoassay PSA Test May Predict Cancer Recurrence
Talactoferrin Second-Line Therapy Increases Survival In Stage IIIB/IV
Researchers Discover Bacteria Common in Colon Cancer Tissue
Colon Cancer Survival Rates Differ Across Racial Lines
NCI Predicts 42 Percent Increase In Number of Senior Survivors
IMRT Less Toxic Than 3D-CRT In Localized Prostate Cancer
NCI CTEP: Approved Trials For The Month of October
FDA Grants Accelerated Approval To Ferriprox for Iron Overload
Trending Stories
- “Backwater to Blockbuster” chronicles the previously untold story of the explosive growth of St. Jude Children’s Research Hospital
In a conversation with Deborah Doroshow, co-authors Chuck Sherr and Bill Evans discuss their collaborative writing process - Prasad’s “deceit,” plus, ODAC’s tough decision against biomarker-based progression assessment (for now)
- DOJ alleges that Yale and UCLA discriminated based on race in medical school admissions
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- How City of Hope is turning microbiome science into better cancer care
